Exendin-4 (1-8) is a minimal N-terminal segment capturing residues implicated in initial receptor interaction. The short peptide aids in defining sequence elements required for activation versus binding. Researchers employ it to probe early conformational events and solvent exposure of the exendin N-terminus. Its simplicity facilitates detailed biophysical and computational studies.
CAT No: E10013
3. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More